🇨🇦 Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI in Canada

Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI (Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI) regulatory status in Canada.

Marketing authorisation

Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Canada

Frequently asked questions

Is Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI in Canada?

Orion Corporation, Orion Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.